Levels of IFNβ were found to be reduced in plasma from both human COVID-19 (+) T2D patients and MHV-infected diabetic mice as compared to their respective infected nondiabetic patients/mice. The gene discussed is IFNB1; the disease is type 2 diabetes mellitus.